Elite Pharmaceuticals, Inc.
ELTP
Get informed when a big investor buys or sells
+ FollowMarket Cap$366.18M
Close$
$0.18
55.2% downside
Current Fair Value
55.2% downsideOvervalued by 55.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $366.18 Million |
|---|---|
| Enterprise Value | $352.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.38 |
| Outstanding Shares | 1,074,115,101 |
Return
| Return on Equity | 54.05% |
|---|---|
| Return on Assets | 34.34% |
| Return on Invested Capital | 38.72% |
Valuation & Multiples
| P/E Ratio | 8.41 |
|---|---|
| PEG | -3.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.51 |
| Enterprise Value to EBIT | 8.04 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
February 17, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%0% |
|---|---|
| Total Invested | $180▼ 26.53% |
| Investors Holding | 10% |
ESG Score
No data